OncoCyte Corporation (LON: 0KCC)
London
· Delayed Price · Currency is GBP · Price in USD
1.918
-0.250 (-11.52%)
Jan 22, 2025, 3:34 PM BST
OncoCyte Revenue
OncoCyte had revenue of $115.00K USD in the quarter ending September 30, 2024, a decrease of -73.19%. This brings the company's revenue in the last twelve months to $709.00K, down -51.54% year-over-year. In the year 2023, OncoCyte had annual revenue of $1.50M with 56.89% growth.
Revenue (ttm)
$709.00K
Revenue Growth
-51.54%
P/S Ratio
n/a
Revenue / Employee
$15.41K
Employees
46
Market Cap
26.79M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |
OncoCyte News
- 15 days ago - Oncocyte names Paul Billings as consulting chief medical officer - Seeking Alpha
- 15 days ago - Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer - GlobeNewsWire
- 16 days ago - Oncocyte Expands Market Opportunity for VitaGraft™ Kidney - GlobeNewsWire
- 6 weeks ago - Oncocyte to Participate in "J.P. Morgan Week" and Host Investor Meetings - Benzinga
- 2 months ago - OncoCyte Corporation (OCX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12 - GlobeNewsWire
- 3 months ago - Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles - GlobeNewsWire
- 5 months ago - OncoCyte Corporation (OCX) Q2 2024 Earnings Call Transcript - Seeking Alpha